DexCom posted strong results for 2Q23, with revenues of $871 million and EPS beating expectations. The company gained new customers and expanded its market share in the United States, particularly in ...
Figure 1. Reversible heart damage in a PA patient: Pre- vs. post-adrenalectomy 68 Ga-FAPI-04 PET/CMR in an APA patient, showing decreased uptake in the basal inferoseptal segment. Image created by ...